BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 21955800)

  • 21. [Study on the correlation of interleukin-13 polymorphism and susceptibility to chronic obstructive pulmonary disease in Chinese Han population].
    Hu RC; Xu YJ; Zhang ZX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):607-11. PubMed ID: 15308043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peer smoking and the nicotinic receptor genes: an examination of genetic and environmental risks for nicotine dependence.
    Johnson EO; Chen LS; Breslau N; Hatsukami D; Robbins T; Saccone NL; Grucza RA; Bierut LJ
    Addiction; 2010 Nov; 105(11):2014-22. PubMed ID: 20840187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung.
    Zienolddiny S; Skaug V; Landvik NE; Ryberg D; Phillips DH; Houlston R; Haugen A
    Carcinogenesis; 2009 Aug; 30(8):1368-71. PubMed ID: 19465454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk.
    Wang J; Spitz MR; Amos CI; Wilkinson AV; Wu X; Shete S
    Cancer; 2010 Jul; 116(14):3458-62. PubMed ID: 20564069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD.
    Saccone NL; Culverhouse RC; Schwantes-An TH; Cannon DS; Chen X; Cichon S; Giegling I; Han S; Han Y; Keskitalo-Vuokko K; Kong X; Landi MT; Ma JZ; Short SE; Stephens SH; Stevens VL; Sun L; Wang Y; Wenzlaff AS; Aggen SH; Breslau N; Broderick P; Chatterjee N; Chen J; Heath AC; Heliövaara M; Hoft NR; Hunter DJ; Jensen MK; Martin NG; Montgomery GW; Niu T; Payne TJ; Peltonen L; Pergadia ML; Rice JP; Sherva R; Spitz MR; Sun J; Wang JC; Weiss RB; Wheeler W; Witt SH; Yang BZ; Caporaso NE; Ehringer MA; Eisen T; Gapstur SM; Gelernter J; Houlston R; Kaprio J; Kendler KS; Kraft P; Leppert MF; Li MD; Madden PA; Nöthen MM; Pillai S; Rietschel M; Rujescu D; Schwartz A; Amos CI; Bierut LJ
    PLoS Genet; 2010 Aug; 6(8):. PubMed ID: 20700436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter polymorphisms and transcript levels of nicotinic receptor CHRNA5.
    Falvella FS; Galvan A; Colombo F; Frullanti E; Pastorino U; Dragani TA
    J Natl Cancer Inst; 2010 Sep; 102(17):1366-70. PubMed ID: 20733116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers.
    Young RP; Hopkins RJ; Hay BA; Epton MJ; Mills GD; Black PN; Gardner HD; Sullivan R; Gamble GD
    Postgrad Med J; 2009 Oct; 85(1008):515-24. PubMed ID: 19789190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Nicotine-dependent Gene Polymorphism and Smoking Cessation in Patients With Lung Cancer.
    Gu F; Zhao C; Jiang T; Li X; Mao Y; Zhou C
    Clin Lung Cancer; 2020 Mar; 21(2):171-176. PubMed ID: 31402126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking.
    Liang G; Miao X; Zhou Y; Tan W; Lin D
    Carcinogenesis; 2004 May; 25(5):773-8. PubMed ID: 14688021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide.
    Bloom AJ; Hartz SM; Baker TB; Chen LS; Piper ME; Fox L; Martinez M; Hatsukami D; Johnson EO; Laurie CC; Saccone NL; Goate A; Bierut LJ
    Ann Am Thorac Soc; 2014 Sep; 11(7):1003-10. PubMed ID: 25072098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple isoforms and differential allelic expression of CHRNA5 in lung tissue and lung adenocarcinoma.
    Falvella FS; Alberio T; Noci S; Santambrogio L; Nosotti M; Incarbone M; Pastorino U; Fasano M; Dragani TA
    Carcinogenesis; 2013 Jun; 34(6):1281-5. PubMed ID: 23430818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
    Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHRNA3 genotype, nicotine dependence, lung function and disease in the general population.
    Kaur-Knudsen D; Nordestgaard BG; Bojesen SE
    Eur Respir J; 2012 Dec; 40(6):1538-44. PubMed ID: 22441734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers.
    Kupiainen H; Kuokkanen M; Kontto J; Virtamo J; Salomaa V; Lindqvist A; Kilpeläinen M; Laitinen T
    COPD; 2016 Aug; 13(4):464-70. PubMed ID: 26751916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis.
    Chen LS; Baker T; Hung RJ; Horton A; Culverhouse R; Hartz S; Saccone N; Cheng I; Deng B; Han Y; Hansen HM; Horsman J; Kim C; Rosenberger A; Aben KK; Andrew AS; Chang SC; Saum KU; Dienemann H; Hatsukami DK; Johnson EO; Pande M; Wrensch MR; McLaughlin J; Skaug V; van der Heijden EH; Wampfler J; Wenzlaff A; Woll P; Zienolddiny S; Bickeböller H; Brenner H; Duell EJ; Haugen A; Brüske I; Kiemeney LA; Lazarus P; Le Marchand L; Liu G; Mayordomo J; Risch A; Schwartz AG; Teare MD; Wu X; Wiencke JK; Yang P; Zhang ZF; Spitz MR; Amos CI; Bierut LJ
    EBioMedicine; 2016 Sep; 11():219-226. PubMed ID: 27543155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction.
    Weiss RB; Baker TB; Cannon DS; von Niederhausern A; Dunn DM; Matsunami N; Singh NA; Baird L; Coon H; McMahon WM; Piper ME; Fiore MC; Scholand MB; Connett JE; Kanner RE; Gahring LC; Rogers SW; Hoidal JR; Leppert MF
    PLoS Genet; 2008 Jul; 4(7):e1000125. PubMed ID: 18618000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme.
    Bray MJ; Chen LS; Fox L; Hancock DB; Culverhouse RC; Hartz SM; Johnson EO; Liu M; McKay JD; Saccone NL; Hokanson JE; Vrieze SI; Tyndale RF; Baker TB; Bierut LJ
    Genet Epidemiol; 2020 Oct; 44(7):748-758. PubMed ID: 32803792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer.
    Spitz MR; Amos CI; Dong Q; Lin J; Wu X
    J Natl Cancer Inst; 2008 Nov; 100(21):1552-6. PubMed ID: 18957677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
    Yang SF; Xu YJ; Xie JG; Zhang ZX
    Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.